AI Engines For more Details: Perplexity Kagi Labs You
Serotonin Receptor Agonism: Quipazine dimaleate salt acts as a non-selective agonist at serotonin 5-HT2 receptors, which are found in various tissues throughout the body, including the central nervous system. By activating these receptors, quipazine dimaleate salt can modulate neurotransmitter release and neuronal excitability, leading to a range of physiological effects.
Neuropharmacological Research: Quipazine dimaleate salt is primarily used as a research tool in neuroscience and pharmacology to study the role of serotonin receptors in various physiological and pathological processes. Its non-selective agonist activity at serotonin 5-HT2 receptors makes it useful for investigating the functions of these receptors in the central nervous system, including their involvement in mood regulation, cognition, and behavior.
Experimental Applications: Quipazine dimaleate salt has been used in experimental models to investigate the neurobiological mechanisms underlying psychiatric disorders such as depression, anxiety, and schizophrenia. By activating serotonin receptors, quipazine dimaleate salt can induce behavioral effects in animal models that may mimic certain aspects of these disorders, providing insights into their pathophysiology and potential therapeutic targets.
Side Effects: Quipazine dimaleate salt can induce a range of physiological and behavioral effects in experimental models, including changes in locomotor activity, body temperature, and sensory perception. These effects may vary depending on factors such as dose, route of administration, and species differences. However, specific side effects in humans are not well-documented due to the limited use of quipazine dimaleate salt in clinical settings.
Therapeutic Potential: While quipazine dimaleate salt itself is not used therapeutically in medical practice, its pharmacological effects on serotonin receptors may have implications for the development of novel treatments for psychiatric and neurological disorders. By understanding the mechanisms of action of quipazine dimaleate salt and related compounds, researchers may identify new drug targets and therapeutic strategies for these conditions.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.1 | 0.1 | |
Acne | 0.2 | -0.2 | |
ADHD | 1.8 | 0.6 | 2 |
Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.1 | 6 |
Allergic Rhinitis (Hay Fever) | 2 | 1.4 | 0.43 |
Allergies | 4.2 | 1.4 | 2 |
Allergy to milk products | 1.1 | 0.8 | 0.38 |
Alopecia (Hair Loss) | 1.2 | 0.1 | 11 |
Alzheimer's disease | 2.7 | 3.6 | -0.33 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1 | 0.4 | 1.5 |
Ankylosing spondylitis | 2.6 | 0.8 | 2.25 |
Anorexia Nervosa | 0.7 | 1.2 | -0.71 |
Antiphospholipid syndrome (APS) | 0.5 | 0.5 | |
Asthma | 3.4 | 1.7 | 1 |
Atherosclerosis | 1.4 | 0.9 | 0.56 |
Atrial fibrillation | 1.6 | 0.8 | 1 |
Autism | 5.9 | 4.3 | 0.37 |
Autoimmune Disease | 0.4 | 0.6 | -0.5 |
Barrett esophagus cancer | 0.4 | 0.1 | 3 |
benign prostatic hyperplasia | 0.1 | 0.2 | -1 |
Biofilm | 1.2 | 1.2 | |
Bipolar Disorder | 0.9 | 1 | -0.11 |
Brain Trauma | 0.8 | 0.7 | 0.14 |
Breast Cancer | 0.3 | 0.3 | |
Cancer (General) | 0.6 | 1.8 | -2 |
Carcinoma | 2.2 | 1.6 | 0.38 |
Celiac Disease | 1.6 | 2 | -0.25 |
Cerebral Palsy | 1 | 0.8 | 0.25 |
Chronic Fatigue Syndrome | 3.5 | 3.8 | -0.09 |
Chronic Kidney Disease | 3.5 | 1.4 | 1.5 |
Chronic Lyme | 0.3 | 0.5 | -0.67 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.8 | 0.8 | 0 |
Chronic Urticaria (Hives) | 0.9 | 0.3 | 2 |
Coagulation / Micro clot triggering bacteria | 0.5 | 0.6 | -0.2 |
Cognitive Function | 1.3 | 0.8 | 0.63 |
Colorectal Cancer | 2.8 | 1.8 | 0.56 |
Constipation | 0.6 | 0.5 | 0.2 |
Coronary artery disease | 1.6 | 1.7 | -0.06 |
COVID-19 | 6.6 | 8.1 | -0.23 |
Crohn's Disease | 4.5 | 2.6 | 0.73 |
Cushing's Syndrome (hypercortisolism) | 0.4 | -0.4 | |
cystic fibrosis | 0.3 | 1.3 | -3.33 |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 0.5 | 0.6 | -0.2 |
Denture Wearers Oral Shifts | 1.1 | 1.1 | |
Depression | 6.3 | 5.2 | 0.21 |
Dermatomyositis | 0.1 | 0.2 | -1 |
Eczema | 1.2 | 1 | 0.2 |
Endometriosis | 1.4 | 1.1 | 0.27 |
Eosinophilic Esophagitis | 0.1 | 0.4 | -3 |
Epilepsy | 2 | 1 | 1 |
erectile dysfunction | 0.5 | 0.2 | 1.5 |
Fibromyalgia | 2.2 | 0.9 | 1.44 |
Functional constipation / chronic idiopathic constipation | 1.9 | 2 | -0.05 |
gallstone disease (gsd) | 2 | 0.6 | 2.33 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.7 | 1.2 | -0.71 |
Generalized anxiety disorder | 1.8 | 1 | 0.8 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.1 | -0.1 | |
Gout | 1.6 | 0.2 | 7 |
Graves' disease | 1.3 | 2.2 | -0.69 |
Gulf War Syndrome | 0.4 | 0.4 | 0 |
Halitosis | 0.8 | 0.1 | 7 |
Hashimoto's thyroiditis | 2 | 0.6 | 2.33 |
Heart Failure | 1.8 | 1.1 | 0.64 |
hemorrhagic stroke | 0.4 | 0.4 | |
Hidradenitis Suppurativa | 0.4 | 0.4 | 0 |
High Histamine/low DAO | 0.9 | 0.2 | 3.5 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.2 | 1.5 |
hyperglycemia | 1.1 | 0.9 | 0.22 |
Hyperlipidemia (High Blood Fats) | 0.7 | 0.4 | 0.75 |
hypersomnia | 0.7 | -0.7 | |
hypertension (High Blood Pressure | 2.1 | 2.7 | -0.29 |
Hypothyroidism | 0.1 | 0.7 | -6 |
Hypoxia | 1.2 | 1.2 | |
IgA nephropathy (IgAN) | 0.8 | 2.6 | -2.25 |
Inflammatory Bowel Disease | 6.1 | 5.3 | 0.15 |
Insomnia | 1.5 | 1.5 | 0 |
Intelligence | 0.9 | 0.1 | 8 |
Intracranial aneurysms | 0.6 | 0.4 | 0.5 |
Irritable Bowel Syndrome | 4.4 | 2.4 | 0.83 |
ischemic stroke | 1.7 | 0.7 | 1.43 |
Liver Cirrhosis | 4.2 | 2.1 | 1 |
Long COVID | 5.1 | 4.4 | 0.16 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 0.7 | 0.9 | -0.29 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.3 | 0.2 | 0.5 |
ME/CFS with IBS | 0.5 | 2.1 | -3.2 |
ME/CFS without IBS | 1.9 | 1.7 | 0.12 |
membranous nephropathy | 0.1 | 0.1 | |
Menopause | 1.2 | 0.5 | 1.4 |
Metabolic Syndrome | 4.7 | 4.4 | 0.07 |
Mood Disorders | 6.5 | 4.1 | 0.59 |
multiple chemical sensitivity [MCS] | 0.7 | 0.2 | 2.5 |
Multiple Sclerosis | 4 | 2.9 | 0.38 |
Multiple system atrophy (MSA) | 0.8 | 0.4 | 1 |
myasthenia gravis | 0.2 | 0.4 | -1 |
neuropathic pain | 0.3 | 1.7 | -4.67 |
Neuropathy (all types) | 0.7 | 0.8 | -0.14 |
neuropsychiatric disorders (PANDAS, PANS) | 0.4 | 0.4 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.2 | 2.8 | 0.14 |
NonCeliac Gluten Sensitivity | 1.5 | 0.4 | 2.75 |
Obesity | 7 | 4.6 | 0.52 |
obsessive-compulsive disorder | 2.6 | 2.1 | 0.24 |
Osteoarthritis | 2.2 | 0.7 | 2.14 |
Osteoporosis | 1.5 | 1.1 | 0.36 |
pancreatic cancer | 0.3 | 0.1 | 2 |
Parkinson's Disease | 4.6 | 4.1 | 0.12 |
Polycystic ovary syndrome | 2.9 | 1.4 | 1.07 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.2 | -1 |
Premenstrual dysphoric disorder | 0.8 | 0.1 | 7 |
primary biliary cholangitis | 0.7 | 0.8 | -0.14 |
Primary sclerosing cholangitis | 1.8 | 2 | -0.11 |
Psoriasis | 2.5 | 1.2 | 1.08 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.8 | 2.5 | 0.92 |
Rosacea | 0.3 | 0.4 | -0.33 |
Schizophrenia | 4.4 | 1.6 | 1.75 |
scoliosis | 0.4 | 0.1 | 3 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 1.9 | 1.6 | 0.19 |
Sleep Apnea | 0.8 | 1.1 | -0.38 |
Slow gastric motility / Gastroparesis | 0.8 | 0.2 | 3 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.1 | 0.3 | 2.67 |
Stress / posttraumatic stress disorder | 1.5 | 2 | -0.33 |
Systemic Lupus Erythematosus | 2.2 | 1.6 | 0.38 |
Tic Disorder | 0.5 | 1.3 | -1.6 |
Tourette syndrome | 0.4 | 0.2 | 1 |
Type 1 Diabetes | 1.7 | 2.2 | -0.29 |
Type 2 Diabetes | 5.4 | 3.2 | 0.69 |
Ulcerative colitis | 3.2 | 3.1 | 0.03 |
Unhealthy Ageing | 2.8 | 0.9 | 2.11 |
Vitiligo | 0.6 | 0.6 | 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]